Trends in Outpatient Influenza Antiviral Use Among Children and Adolescents in the United States.

ABSTRACT:

Background

Influenza antivirals improve outcomes in children with duration of symptoms <2 days and those at high risk for influenza complications. Real-world prescribing of influenza antivirals in the pediatric population is unknown.

Methods

We performed a cross-sectional study of outpatient and emergency department prescription claims in individuals <18 years of age included in the IBM Marketscan Commercial Claims and Encounters Database between July 1, 2010 and June 30, 2019. Influenza antiviral use was defined as any dispensing of oseltamivir, baloxavir, or zanamivir. The primary outcome was the rate of antiviral dispensing per 1000 enrolled children. Secondary outcomes included antiviral dispensing per 1000 influenza diagnoses and inflation-adjusted costs of antiviral ag

SUBMITTER: Antoon JW 

PROVIDER: S-EPMC10681853 | biostudies-literature | 2023 Dec

REPOSITORIES: biostudies-literature